| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/19/2002 | US6359002 Method for treating a patient with neoplasia by treatment with a platinum coordination complex |
| 03/19/2002 | US6358987 For therapy and prophylaxis of rheumatoid arthritis, osteoarthritis, osteopenias such as osteoporosis, periodontitis, gingivitis, corneal epidermal or gastric ulceration, and tumour metastasis, invasion and growth |
| 03/19/2002 | US6358985 Inhibitors of prenyl-protein transferase |
| 03/19/2002 | US6358983 Heterocyclically substituted α-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
| 03/19/2002 | US6358978 Substituted benzimidazoles |
| 03/19/2002 | US6358976 For therapy and prophylaxis of cancer metastasis, diabetic retinopathy, neovascular glaucoma, thrombosis, restenosis, osteoporosis, or macular degeneration |
| 03/19/2002 | US6358970 Integrin receptor antagonists |
| 03/19/2002 | US6358968 N-substituted urea inhibitors of farnesyl-protein transferase |
| 03/19/2002 | US6358962 6,7-Dimethoxyquinazolines and therapeutic use thereof |
| 03/19/2002 | US6358961 Farnesyltransferase inhibiting quinazolinones |
| 03/19/2002 | US6358957 Cancer therapy |
| 03/19/2002 | US6358956 Inhibitors of prenyl-protein transferase |
| 03/19/2002 | US6358954 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 03/19/2002 | US6358953 Administering pterin metal complex as anticarcinogenic agents and viricides |
| 03/19/2002 | US6358952 Combination of benzoquinazoline antifolates and protecting agents |
| 03/19/2002 | US6358948 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 03/19/2002 | US6358947 Tetracyclic progesterone receptor modulator compounds and methods |
| 03/19/2002 | US6358940 Modified 2-Alkoxyestradiol derivatives with prolonged pharmacological activity |
| 03/19/2002 | US6358937 Administering phosphatidic acid and lipid to treat drug abuse, addiction, or withdrawal and/or alcoholism |
| 03/19/2002 | US6358936 Modified doxorubicin |
| 03/19/2002 | US6358923 Preventing and diagnosing blood, genetic, and nervous system disorders associated with decreased genetic expression |
| 03/19/2002 | US6358920 Nonapeptide anticarcinogenic and antimetastasis agents |
| 03/19/2002 | US6358732 Nucleotide sequences preferential polypeptides for use in the treatment of defects in central nervous system |
| 03/19/2002 | US6358710 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 |
| 03/19/2002 | US6358707 Polynucleotide sequences coding polypeptide associated with cellular secretion; for use in treatment of diabetes, stroke, atherosclerosis, restenosis, thrombosis, autoimmune disease, psoriasis, arthritis, crohn's, and inflammatory defects |
| 03/19/2002 | US6358695 Determining compounds that activate or inhibit a g-protein receptor by exposing cells expressing the polypeptide on the surface with a test compound to allow binding and detect a signal in response to binding of agent to the polypeptide |
| 03/19/2002 | US6358524 Target cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their use |
| 03/19/2002 | US6358491 Somatostatin analogs |
| 03/19/2002 | CA2236673C (-)cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 03/19/2002 | CA2232488C Cancer chemoprotective food products |
| 03/19/2002 | CA2179521C 2,4-disulphophenyl butylnitrone, its salts and their use as pharmaceuti cal spintraps |
| 03/19/2002 | CA2173963C Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 03/19/2002 | CA2099779C Mixed specificity fusion proteins |
| 03/19/2002 | CA2050331C Ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 03/19/2002 | CA1341348C Human tumor necrosis factor |
| 03/15/2002 | CA2357155A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 03/14/2002 | WO2002021138A2 The m30 gene family and the utilization thereof |
| 03/14/2002 | WO2002021134A2 Methods of diagnosing breast cancer and screening for modulators |
| 03/14/2002 | WO2002020846A2 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure |
| 03/14/2002 | WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | WO2002020814A1 Self-rearranging dna vectors |
| 03/14/2002 | WO2002020813A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 03/14/2002 | WO2002020807A1 L-methionine $g(g)-lyase with modified function |
| 03/14/2002 | WO2002020788A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020786A2 Kinase d interacting protein |
| 03/14/2002 | WO2002020770A1 Method of screening antitumor agent by using interaction between arf protein and hk33 protein |
| 03/14/2002 | WO2002020769A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | WO2002020768A2 Caveolin peptides and their use as therapeutics |
| 03/14/2002 | WO2002020767A2 G-csf analog compositions and methods |
| 03/14/2002 | WO2002020766A2 G-csf analog compositions and methods |
| 03/14/2002 | WO2002020762A2 Tnf receptor-like molecules and uses thereof |
| 03/14/2002 | WO2002020759A2 A non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties |
| 03/14/2002 | WO2002020743A1 A new polypeptide- human i kappa b kinase 15 and the polynucleotide encoding it |
| 03/14/2002 | WO2002020736A2 Proteases |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020621A1 Tetraphenylporphyrin derivatives and compositions comprising the same |
| 03/14/2002 | WO2002020620A2 Monoclonal antibody against ovarian carcinoma |
| 03/14/2002 | WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 03/14/2002 | WO2002020617A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 03/14/2002 | WO2002020616A1 Hla-a2.1 binding peptides and their uses |
| 03/14/2002 | WO2002020608A1 A new polypeptide- human lymph enhanced factor 42 and the polynucleotide encoding it |
| 03/14/2002 | WO2002020607A1 A NEW POLYPEPTIDE-HUMAN BIPHENYL HYDROLASE-RELATED PROTEIN (Bph-rp)16.06 AND THE POLYNUCLEOTIDE ENCODING IT |
| 03/14/2002 | WO2002020606A1 A new polypeptide- human hearing defect-related protein 38.39 and the polynucleotde encoding it |
| 03/14/2002 | WO2002020605A1 A NEW POLYPEPTIDE-HUMAN CELL CYCLIN-E BINDING PROTEIN 1(Ceb1)113-70.07 AND THE POLYNUCLEOTIDE ENCODING IT |
| 03/14/2002 | WO2002020604A1 A new polypeptide- human double-stranded rna binding protein 11 and the polynucleotide encoding it |
| 03/14/2002 | WO2002020603A1 A new polypeptide- human tropomodulin 25.08 and the polynucleotide encoding it |
| 03/14/2002 | WO2002020600A1 A new polypeptide- human zinc finger protein 10.45 and the polynucleotide encoding it |
| 03/14/2002 | WO2002020599A1 A new polypeptide- human transcription regulation factor zfm1 isomer 19.47 and the polynucleotide encoding it |
| 03/14/2002 | WO2002020598A1 Mucin |
| 03/14/2002 | WO2002020590A1 A novel polypeptide-phosphoenolpyruvate-dependent sugar phosphotransferase 33 and the polynucleotide encoding said polypeptide |
| 03/14/2002 | WO2002020589A1 A novel polypeptide-the human retinoblastoma binding protein 19.91 and the polynucleotide encoding said polypeptide |
| 03/14/2002 | WO2002020588A1 A novel polypeptide-human transcriptional control factor zfm1 isomer 25.63 and the polynucleotide encoding said polypeptide |
| 03/14/2002 | WO2002020587A1 A novel polypeptide-human nadh dehydrogenase subunit i-12.43 and the polynucleotide encoding said polypeptide |
| 03/14/2002 | WO2002020586A1 A novel polypeptide-human large protein 10.23 and the polynucleotide encoding said polypeptide |
| 03/14/2002 | WO2002020581A1 A novel polypeptide-rna polymerase 11 related protein 11.33 and the polynucleotide encoding said polypeptide |
| 03/14/2002 | WO2002020580A1 A novel polypeptide-human tnfr/ngfr protein 15 that contains cytochrome c structural domain and the polynucleotide encoding said polypeptide |
| 03/14/2002 | WO2002020560A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | WO2002020536A1 Tetraphenylbacteriochlorin derivatives and compositions containing the same |
| 03/14/2002 | WO2002020527A1 Soluble compounds for the inhibition of multidrug resistance and pharmaceutical compositions thereof |
| 03/14/2002 | WO2002020526A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/14/2002 | WO2002020525A2 Protein tyrosine phosphatase inhibitor |
| 03/14/2002 | WO2002020524A1 Oxindole derivatives |
| 03/14/2002 | WO2002020513A1 Oxindole derivatives |
| 03/14/2002 | WO2002020512A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 03/14/2002 | WO2002020500A2 Materials and methods to potentiate cancer treatment |
| 03/14/2002 | WO2002020495A2 Inhibitors of glycogen synthase kinase 3 |
| 03/14/2002 | WO2002020486A2 Picolinic acid derivatives for the prevention and treatment of cancer in animals |
| 03/14/2002 | WO2002020483A1 Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 03/14/2002 | WO2002020479A1 Substituted oxindole derivatives as tyrosine kinase inhibitors |
| 03/14/2002 | WO2002020478A1 N-benzylindole-3-acetic acid derivatives for use in the treatment of drug resistan cancer |
| 03/14/2002 | WO2002020475A2 Inhibitors of serine protease activity of matriptase or mtsp1 |
| 03/14/2002 | WO2002020463A2 Fxr modulators |
| 03/14/2002 | WO2002020112A1 Process for selectively extracting bioactive components |
| 03/14/2002 | WO2002020092A1 Use of serum response factor (srf) modulator for treating srf related diseases |
| 03/14/2002 | WO2002020060A1 Vp22 protein/nucleic acid aggregates, uses thereof |
| 03/14/2002 | WO2002020053A1 Hla binding peptides and their uses |
| 03/14/2002 | WO2002020039A2 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites |
| 03/14/2002 | WO2002020035A1 Hla binding peptides and their uses |